Physician profile
Bincy Abraham
NPI 1427309947
$9,230.35
in general payments reported to CMS, 2019-2025
7 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,952 · 2022: $5,045 · 2023: $56.56 · 2024: $36.69 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,800.00 | 2021-2022 | |
| Abbott Laboratories | $162.16 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Pfizer INC. | $105.53 | 2025 | |
| Abiomed | $56.56 | 2023 | Impella |
| Astrazeneca Pharmaceuticals Lp | $51.62 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $33.91 | 2025 | Rebyota |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.57 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bincy Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.